Sangamo Therapeutics Inc (NASDAQ: SGMO)’s Stock Is Down -70.12% Since The Beginning Of The Year, Likely To Sustain The Trend In 2024
During the last session, Sangamo Therapeutics Inc (NASDAQ:SGMO)’s traded shares were 1.16 million, with the beta value of the company hitting 1.40. At the end